secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2024-02-26T23:59:59+00:00
Accession:  0001193125-24-044886
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.05
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio awards $805K bonuses, 3.2M options, RSUs; sets 2024 exec pay
------------------------------------------------------------------------

- 2023 bonuses: Soon-Shiong $232,875, Adcock $298,500, Sachs $273,980; payable by March 15, 2024.
- Option grants: Soon-Shiong 1.19M NSOs, Adcock 1.59M ISOs, Sachs 424K ISOs at $5.24 strike.
- RSU grants: Soon-Shiong 342,987, Adcock 457,317, Sachs 121,951; vest ratably over 3 years.
- 2024 salary/target bonus: Soon-Shiong $621K/75%, Adcock $796K/75%, Sachs $575K/50%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000119312524044886/0001193125-24-044886-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000119312524044886/d785996d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-044886

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer